U.S. Intravenous Solutions Market Size To Reach $9.8 Billion By 2033

U.S. Intravenous Solutions Market Growth & Trends

The U.S. intravenous solutions market size is expected to reach USD 9.8 billion by 2033, registering a CAGR of 9.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is experiencing growth due to the increasing prevalence of disease and a rise in surgical procedures. The aging population, which is more prone to non-communicable diseases such as cancer, neurological, cardiovascular disorders, and spinal injuries, is also driving market expansion. In October 2024, Fresenius Medical Care announced initiatives to mitigate disruptions in dialysis care. The company is enhancing the production of PD and IV solutions by leveraging its global production facilities. Prompted by the Department of Health & Human Services, Fresenius Medical Care is committed to meeting the demand for IV fluids and peritoneal dialysis (PD) products through improved production strategies.

IV hydration therapy effectively treats severe dehydration, especially in people with chronic conditions like diabetes or kidney diseases, by replenishing the body's electrolyte balance. The primary treatment is saline solution, water mixed with sodium chloride. Solutions with sugars like glucose, dextrose, or levulose are also standard. In December 2023, Baxter, a prominent company in infusion therapies and technologies, finished the first stage of its IV bag recycling trial in partnership with Northwestern Medicine. This program has successfully diverted over six tons of PVC IV bag material from being disposed of in landfills. If these bags were placed end to end, they would stretch across Chicago, demonstrating the project's contribution to environmental preservation.

 Request a free sample copy or view report summary: U.S. Intravenous Solutions Market Report

U.S. Intravenous Solutions Market Report Highlights

• The increasing incidence of cancer is a key driver for the U.S. intravenous solutions industry, as cancer patients frequently require IV therapy for chemotherapy administration, hydration, electrolyte balance, and supportive care.

• The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high.

• For instance, in May 2025, Otsuka and ICU Medical announced a joint venture to strengthen IV solution supply in North America by combining global manufacturing scale with regional production and distribution capabilities.

• Based on the product, the TPN segment accounted for the largest market share of over 67.3% in 2025 and is expected to grow at the fastest CAGR of 9.6% over the forecast period.

• The single-dose amino acid solution segment dominated the U.S. intravenous solutions market, accounting for the largest share in 2025, driven by its critical role in parenteral nutrition for patients unable to meet protein requirements orally or enterally.

• The hospitals segment dominated the U.S. intravenous solutions industry, accounting for a dominant share of 50.8% in 2025, primarily due to the high volume of inpatient procedures and the extensive use of IV therapies across emergency, surgical, and critical care settings

• The home segment is expected to grow at a significant CAGR over the forecast period, driven by the increasing shift of healthcare delivery from hospitals to home-based settings.

U.S. Intravenous Solutions Market Segmentation

Grand View Research has segmented the U.S. intravenous solutions market report based on type, nutrients, and end use:

U.S. Intravenous Solutions Type Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)

• Total Parenteral Nutrition

• Peripheral Parenteral Nutrition

U.S. Intravenous Solutions Nutrients Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)

• Carbohydrates

• Vitamins & Minerals

• Single-dose Amino Acids

• Parenteral Lipid Emulsion

• Others

U.S. Intravenous Solutions End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)

• Home

• Hospitals

• Infusion Centers

List of Key Players in U.S. Intravenous Solutions Market

• Fresenius Kabi AG

• B. Braun SE

• Baxter

• Otsuka Pharmaceutical Co., Ltd.

• Pfizer, Inc.

• JW Life Science

• CSL Vifor (formerly Vifor Pharma)

• ICU Medical, Inc.

• Amphastar Pharmaceuticals, Inc.